Directory · EE
Biotechnology Research in Estonia
A register of firms and the professionals working at them in the Biotechnology Research sector based in Estonia. Browse the public index, then filter or export on Kipplo.
Companies
35 on file
Solis Biodyne
With a professional team of 50+ local and international members, Solis BioDyne is a pioneering company in making stable, sustainable, and cost-effective PCR, qPCR, reverse transcription, and isothermal amplification reagents. One of the leading reagent suppliers in Europe today, we have been developing and producing life science reagents since 1995. Our production and product development takes place in a state-of-the-art laboratory where strict production and quality control procedures enable us to uphold the highest quality standards. We are in possession of the ISO 9001 certificate and ISO 13485 certificate. This makes us a trusted trademark worldwide. By applying Stability TAG Technology in all our products, we can confidently say that the most stable, sustainable, and cost-effective PCR, qPCR, isothermal amplification, and reverse transcription reagents are developed in Solis BioDyne. And thanks to room temperature shipping, our entire product range is shipped without ice to more than 100 countries in the world. With quality, innovation, reliability, and knowledge as core values- our research and production team constantly strives to develop new, sustainable, and user-friendly molecular biology products to be one of the trendsetters and keep pace with new emerging PCR technologies- our sales and marketing team offers personalized and prompt customer support while actively developing new customer-oriented strategies in order to find flexible solutions to meet the needs of each individual researcher. Our growing clientele list includes top research institutes and biotech companies. Solis BioDyne has partners in both private and public sectors, with cooperation projects ranging from custom development and production to scientific research. We would enjoy the opportunity to partner with you.
51 to 200 staff
Asper Biogene
Asper Biogene is a genetic testing company focused on diagnostics of hereditary diseases. Our comprehensive testing options vary from single gene analysis to whole genome sequencing. In addition to ready-to-use tests, we develop and implement custom-made tests and solutions in order to meet the specific needs of the health care providers and their patients. The quality of our testing procedures is confirmed by CLIA, ISO 15189:2012 and ISO 9001:2015 certifications.#genetictesting #diagnostics #NGSpanels #WES #WGS
11 to 50 staff
Cellin Technologies
Founded in 2013, Cellin Technologies OÜ pioneered the regenerative medicine arena in Estonia by specializing in analysis, design and production of cell therapy products. Cellin’s scientific foundation is a set of tools and methods that allow to develop a deep understanding between the stems cells and their biological function and the manufacturing process.
11 to 50 staff
Biocc Llc
BioCC carries out internationally recognized R&D to create, develop and implement innovative biotechnological solutions for feed, food supplements, integrating its and international knowledge in the field of microbiology, biochemistry, genetics, metabolomics, genomics, physiology, and medicine. One of BioCC's greatest achievements is Lactobacillus plantarum strain TENSIA®, which is a multipotent microbe of a healthy child origin with the ability to produce compounds possessing direct or indirect blood pressure lowering effects, antimicrobial activity against food-borne pathogens and has moderate antioxidative activity. BioCC LLC is the lead partner of EstLat project Bio4Asia. https://estlat.eu/en/estlat-results/bio4asia.html The articles and posts reflect the views of the author. The managing authority of the programme is not liable for how this information may be used.
11 to 50 staff
Protobios Llc
Protobios (PB) is an Estonian biotechnology company founded in October 2003, and is positioning itself as a developer of new diagnostic tests and also as a service provider in the field of immunome analysis Discovering potential of immunoprofiling A drop of human blood is presumed to have 10 powered 11 specific antibodies that recognize different immunogens (natural antigen epitopes and antigenic mimics, mimotopes). Although the potential size of the human immunoglobulin repertoire has been estimated, the understanding of its overall involvement in the immune response has remained elusive, mainly because we are not yet able to decipher it. Protobios' novel immunoprofiling technology MVA (Mimotope Variation Analysis) has overcome that problem. MVA technology enables to obtain quantitative and qualitative antibody binding profiles (immunoprofiles). A binding profile can be made to describe a single molecule up to individuals or populations. An immunoprofile describes the state of the immune system and its ability to protect the body. That is considered an innovative tool interpreting health related data for diseases; health conditions and propels the caregivers towards a new level of understanding regarding the prevention and treatment. Alternatively allows MVA to offer reliable services such as epitope mapping, antibody analyses, immunogenicity assessment etc. to biotechnology industry. MVA technology is based on screening of combinatorial peptide display library, next generation DNA sequencing and proprietary bioinformatics analysis. Learn more about MVA, its applications on
11 to 50 staff
Estagar
Est-Agar is the world’s only producer of furcellaran — a unique, plant-based hydrocolloid derived from red seaweed (Furcellaria lumbricalis). With over 60 years of experience, we deliver clean-label, high-performance texturizing solutions for food, beauty, and biotech manufacturers seeking reliable alternatives to conventional hydrocolloids. Our seaweed is responsibly harvested in Saaremaa, Estonia, under strict marine institute quotas, ensuring full traceability, consistent quality, and a secure EU-based supply chain. Sustainability is built into our process, supported by scientific oversight and long-term collaboration with research institutions. Furcellaran stands out for its unique functional performance: smooth and elastic textures, strong gel strength at low dosages, excellent stability, and clean sensory properties. Available in both flakes and powder, it supports a wide range of applications, from confectionery and dairy to cosmetics and nutraceuticals. Beyond our core ingredient, Est-Agar continues to invest in R&D to improve production efficiency, expand applications, and develop new plant-based solutions from marine biomass. We don’t compete on volume — we compete on quality, trust, and long-term performance. Trusted ingredient. Tangible results — products powered by furcellaran.
11 to 50 staff
Funki
FUNKI wants to serve future-conscious consumers with highly nutritious but most importantly the tastiest meat alternatives. We offer cleanest protein and fiber, which are less processed than other meat alternatives on the market. FUNKI promises delicious and easy to prepare everyday protein products. FUNKI is all about eating good while feeling good – together we can save the planet one delicious bite at the time.
1 to 10 staff
Myceen
MYCEEN is a cleantech company that focuses on novel materials by combining mushroom mycelium with organic leftovers from other industries. It's a perfect example of circular economy and a breakthrough technology that stores more carbon than the whole production process emits. Please reach out to us to use our high-performing insulation and acoustic materials for the carbon-neutral construction industry. We are open to interesting collaborations, design or architecture projects, custom solutions, and exhibitions.
1 to 10 staff
Chemestmed
We are pioneering drug discovery through mRNA regulation. Chemestmed is on the mission to develop disruptive therapeutics for a variety of neurodegenerative and neuropsychiatric disorders, metabolic diseases and viral infections.
11 to 50 staff
Intraclear Biologics
IntraClear Biologics is a new generation bioengineering company. Our goal is to help humanity put ageing under full medical control. Unlike most current compensatory therapies aimed at reducing the symptoms of age-related diseases, the therapies we are developing are aimed at their very causes — molecular and cellular damage that accumulates in the human body during life. We develop protocols for determining the levels of molecular and cellular damage, which are a real measure of the biological age of a person and the effectiveness of therapies used.
1 to 10 staff
Wnwn.Skin
WNWN: short for Waste Not Want Not, pronounced:"Win-Win." Our long-term vision is to eliminate the need for virgin raw materials in the cosmetic industry through the valorization of agri-food plant byproducts using fermentation and green chemistry extraction techniques. WNWN is a member of Tartu Biopark Incubator, an alumnus of Prototron, EIT Food's EWA program, and Red Brick Tampere accelerator. Winner of the NOBALIS program. Currently in the Spring 2024 batch of Baltic Impact Accelerator.
1 to 10 staff
Bioengineering Taltech
The Food Tech and Bioengineering lab at Tallinn University of Technology (TalTech) is committed to developing sustainable solutions in the bioeconomy sector. Launched in January 2021 and led by Professor Petri-Jaan Lahtvee, the lab specializes in bioinformatics, metabolic engineering, and bioprocess optimization, including the innovative use of 3D printing for creating living materials. We have established the Design-Build-Test-Learn cycle of cell factory design and bioprocess optimization. Our research focuses on creating microbial cell factories to convert various waste materials into valuable products, thereby addressing global challenges in biosustainability. This involves the sustainable production of food, feed, bio-chemicals, and materials. The lab emphasizes collaboration, professional excellence, and the education of future scientists and engineers to drive forward scientific breakthroughs and the application of these in industrial biotechnology
11 to 50 staff
Competence Center Of Food And Fermentation Technologies
Competence Center of Food and Fermentation Technology (CCFFT) was founded on June 15th 2004 by Tallinn University of Technology and six partner companies. CCFFT offers extensive knowledge both in food and fermentation science. The technological base of CCFFT is regarded contemporary and sufficient for carrying out research in the food and fermentation technology field. The computer controlled systems of the CCFFT allow to carry out even the most complex cultivation procedures, gastrointestinal simulations etc. as well as physical and chemical analysis of food- and bioproducts. One of the main topics of the R&D activities in CCFFT is systems biology, which involves development of new cultivation techniques, simultaneously with cell physiological models, in which our center has accumulated a remarkable competence. CCFFT research projects are co-funded by Enterprise Estonia and by our customer companies. This gives our clients a unique opportunity to do exhaustive R&D studies with distributed costs. CCFFT solutions are custom-made for each of our client:* advanced microorganism cultivation technologies * systems biology of microorganisms * food stability, quality and healthiness * modeling human gastrointestinal tract
11 to 50 staff
Decomer Technology
Decomer Technology is developing a novel water-soluble and edible packaging material as well as products thereof. The material is plant-based, tasteless, transparent and hypoallergenic and can be used in food, detergent, pharmaceutical, agricultural and other industries. We combine convenience and sustainability.
1 to 10 staff
Dxlabs Llc
dxlabs LLC offers an ISO 17025 accredited food allergen detection service for food manufacturers. Our portfolio includes the quantitative detection of all food allergens listed by the EU legislation. Why test for allergens? As allergies become ever more common among the consumers, the manufacturers have a growing responsibility to keep the products safe. This means correct labelling of the products and making sure that the ingredients match the labels. During the manufacturing process, cross-contamination may become a problem due to insufficient cleaning of the production lines or surfaces. Contamination even on the field may render a gluten free product allergenic. The laboratory analysis of the raw materials and end products minimises the risks of the contaminated product reaching the market.
1 to 10 staff
Genecode
GeneCode is a private pharmaceutical development company focused on the development of disease-modifying therapeutics to combat neurodegeneration. The GDNF Mimetics platform leverages the disease-modifying properties of GDNF to small molecules with drug-like properties. R&D-wise, GeneCode has remarkably improved the properties of the identified hits, making them more active and effective, drug-like and better show their ability to combat neurodegeneration in Parkinson´s disease (PD).
1 to 10 staff
Kurglab
A molecular biomedicine laboratory in Institute of Technology, University of Tartu in Estonia. We focus on RNA methyltransferases, MAGEA proteins, cancer biomarkers and extracellular vesicles. Check out our webpage at kurglab.ee!
1 to 10 staff
The Micron Group
Founded in 1996 by a group of highly experienced healthcare professionals with a wide range of pharmaceutical industry and academic experience, The Micron Group has grown around this core of expertise, and now has offices in the UK, USA and South Africa. From these locations The Micron Group has global capabilities to deliver full clinical outsourcing, data management, medical communications and consultancy services. While initially an anti-infective specialized organisation, and still an authority in this field, The Micron Group has evolved to posses the expertise required to deliver our full range of services in the fields of respiratory, cardiovascular, neurology, dermatology, endocrinology, rheumatology, and oncology. Regardless of the field or the project, The Micron Group consistently strives to deliver a service that is flexible, preemptive and precise, ensuring projects are delivered on time and on budget, while going above and beyond expectation.
51 to 200 staff
Roche Estonia
Roche Eesti OÜ kuulub Šveitsi ettevõtte Roche kontserni, mis on maailma suurim biotehnoloogiaettevõte. Roche’i tooted on kohandatud vastavalt konkreetsete patsiendirühmade vajadustele lähtudes eesmärgist oluliselt parandada patsiendi tervist, elukvaliteeti ja eluiga. Roche’i ravimid aitavad peamiselt vähkkasvajate, hulgiskleroosi, reumaatiliste haiguste ja hemofiiliaga inimesi. Meie missioon täna ja homme on luua lisaväärtust tervishoiusüsteemis, keskendudes meie teadmistele farmaatsia-ja diagnostikavaldkonnas. Roche Eesti soovib olla usaldusväärne partner kõikidele tervishoiusektori osapooltele seades keskmesse patsiendi vajadused. Peame oluliseks panustada Eestis lisaks diagnostika ja ravikvaliteedi parandamisvõimalustele ka meditsiinipersonali koolitamisse, patsientide teadlikkuse tõstmisesse ning väärtuspõhisesse tervishoidu. Roche Eestil on vastutustundliku ettevõtluse KULD märgis, mille saavad ettevõtted, kelle tegevus on suunatud pikaajalisele jätkusuutlikule kasvule, mis mõistavad läbipaistva tegevuse tähtsust ning tunnustavad tugeva meeskonna tähtsust. Roche Eesti on osaks Tööandjate Keskliidu 2% klubist, kuhu kuuluvad ettevõtted, mis investeerivad oma ettevõtete käibest vähemalt 2% või miljon eurot aastas teadus-arendustegevusse. Klubi üks eesmärkidest on populariseerida teadus- ja arendustegevust ettevõtjate hulgas läbi eeskujude, edulugude ja ideede. Roche Eestile on omistatud tervist edendava töökoha märgis, mis antakse neile organisatsioonidele, kus väärtustatakse töötajaid ja tegeletakse järjepidevalt turvalise, tervist väärtustava, tervislikke eluviise ning valikuid soodustava Roche Estonia LinkedIn leht ei ole ravimite kõrvaltoimetest teatamiseks. Kui kahtlustate, et teil on tekkinud ravimi kõrvaltoime, pidage nõu oma arsti, apteekri või meditsiiniõega. Kõrvaltoimetest võite ka ise teatada ravimiamet.ee kaudu.
11 to 50 staff
As Baltimere Invest Bmi
Harnessing the value and hypo-allergenic nature of rapeseed protein isolates and concentrates in feeding the world. The goal of AS Baltimere Invest (BMI) is to commercialize the production of rapeseed protein isolates and concentrates, thus creating a new, healthy, and economically sensible alternative to animal proteins to meet the continually increasing protein demands of the growing global population. Using proprietary technologies BMI is now building out its Technology Demonstration Plant to go live in mid 2018. It will produce protein flours, textured protein concentrates and at least two basic types of protein isolates, a readily soluble protein and a precipitated protein, all of which are intended for use in various food applications. All of these protein products have good functional properties and a high nutritional value. The by-products and waste materials will be used as fish/animal feed and fuel.
11 to 50 staff
Quantum Research Lab
Quantum research lab is a preclinical bioimaging startup addressing the challenges in molecular imaging for precision medicine. By offering tailor-made services to scientific institutions, we help integrate machine learning toolboxes into their research covering areas such as SPECT, PET, MRI image processing, hyperpolarized MRI, and NMR spectroscopy signal processing. Our approach leverages both supervised and unsupervised learning, as well as developing experimental solutions incorporating the latest advancements in hybrid neural networks for tomographic reconstruction and denoising. Our goal is to empower scientists with a reproducible, consistent, and sustainable workflow through concise collaboration projects.
1 to 10 staff
Fibenol
Fibenol is a company that produces wood-based raw materials and is dedicated to redefining the forest industry through sustainable production and new-age technology. Our mission is to add value to industries by transforming wood residues to replace fossil-based materials with wood-based materials. At our flagship plant, we use a unique fractionation technology that easily converts woody residues into a processable liquid in just 20 seconds. From that, we further extract biobased building blocks that can be turned into much-needed low-carbon products for customers looking to switch over from fossil-based materials to bio-based raw materials in various industry fields such as bio-based plastics, construction materials, cosmetics, or even the future of pharmaceuticals. Currently, we have three primary products: • LIGNOVA ™ - can be used directly or processed further into a variety of biochemicals, coatings and adhesives, resins, and more. • Cellulosic Sugars - a sustainable alternative for the whole bioprocessing industry to produce many platform chemicals. • Microcrystalline Cellulose (MCC)- can be used as a strength additive in papermaking, as a thickener, emulsion stabilizer, and more. To find out more about Fibenol products visit our website and request a desired sample for testing: fibenol.com/products
51 to 200 staff
Vectiopep
Vectiopep is developing peptide-based nucleic acid delivery technology. Combined with the new generation mRNA therapeutics, we empower the body's immune system to fight cancer. Vectiopep is a privately-held biotechnology company, founded by a group of researchers who have more than 10 years of expertise in developing and optimizing delivery technologies for nucleic acids.
1 to 10 staff
Edilabs
EdiLabs is a plant-based, platform-driven biotech, engineering breakthrough therapeutics across a sustainable pipeline. We combine deep expertise in neuroscience, vaccine development and plant-based expression technologies with strategic partnerships to advance novel programmes.
1 to 10 staff
